Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XOM vs GSK✓SelectedUSD · GSKXOM vs GSK performance historyLatest closeAs of+0.67%11/20
Stock and ETF performance explorer

XOM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+40.3%
GSK return
+6.1%
Excess return
+34.2%
Maximum drawdown
-20.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.7%-0.1%+0.8%+0.7%
7D-5.6%-5.3%-0.3%-6.2%
30D-9.6%-3.7%-5.9%-9.9%
3M-3.1%-7.3%+4.2%-3.7%
6M+3.7%-4.2%+7.9%+3.5%
YTD+36.5%+0.9%+35.6%+36.2%
1Y+40.3%+7.3%+33.1%+40.3%
All+40.3%+6.1%+34.2%+40.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling